Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000726971 | SCV000241232 | benign | not provided | 2019-08-02 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25904555, 22833210, 26283219, 27839871) |
Athena Diagnostics | RCV000187635 | SCV000613546 | benign | not specified | 2017-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084905 | SCV000638223 | likely benign | Landau-Kleffner syndrome | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000726971 | SCV000704581 | uncertain significance | not provided | 2017-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002314719 | SCV000849384 | benign | Inborn genetic diseases | 2018-12-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000726971 | SCV004141103 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | GRIN2A: PS4:Supporting, BS1 |
Prevention |
RCV003907658 | SCV004726388 | likely benign | GRIN2A-related disorder | 2022-05-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |